Total Return chart Lineage Cell Therapeutics, Inc.
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
17:03:47 19/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.9500 USD | -2.89% |
|
+2.77% | -41.29% |
| 10-01 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
















